最終更新日:2022/12/24

Other early phase trials are based on improving the inflammation that is a result of sickle vasoocclusion and vasculopathy by reducing the activation of invariant natural killer T-cells (NCT01788631) and using a statin as an anti-inflammatory (NCT01702246).

編集履歴(0)

Sentence quizzes to help you learn to read

編集履歴(0)

ログイン / 新規登録

 

アプリをダウンロード!
DiQt

DiQt(ディクト)

無料

★★★★★★★★★★